Platinum catalyst-functionalized cylindrical graft copolymer micelles for dual catalytic and cytotoxic activity†

IF 4.7 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY
Kyosuke Seryu, Chieri Inada and Tomoki Nishimura
{"title":"Platinum catalyst-functionalized cylindrical graft copolymer micelles for dual catalytic and cytotoxic activity†","authors":"Kyosuke Seryu, Chieri Inada and Tomoki Nishimura","doi":"10.1039/D5MA00518C","DOIUrl":null,"url":null,"abstract":"<p >Catalytic prodrug activation offers a promising approach to cancer therapy, but integrating catalytic and therapeutic functions within a single platform remains challenging. In addition, low-molecular weight metal catalysts suffer from rapid clearance and limited <em>in vivo</em> efficacy. Here, we present a platinum complex-conjugated polymeric micellar system, constructed from amphiphilic poly(acrylic acid)-<em>graft</em>-poly(propylene oxide), which self-assembles into short cylindrical micelles (<em>ca.</em> 50 nm in length) in aqueous solution. The micelles are functionalized with a cisplatin-derived Pt(<small>IV</small>) metal complex, which is released under reductive conditions and converted into catalytically active Pt(<small>II</small>) species capable of deprotecting an <em>N</em>-propargylated 5-fluorouracil prodrug. The catalytic transformation proceeds more efficiently under mildly acidic conditions (pH = 6.0), achieving up to 35% conversion after 96 hours. Cell viability assays using CT26 cancer cells showed a decrease in viability from 60% (Pt-micelle alone) to below 50% when combined with the prodrug, indicating dual catalytic and cytotoxic activity <em>in vitro</em>. These findings provide a proof-of-concept for a dual-functional nanocarrier system capable of localized prodrug activation and therapeutic action, offering a promising strategy for advancing metal-catalyzed cancer therapy.</p>","PeriodicalId":18242,"journal":{"name":"Materials Advances","volume":" 17","pages":" 6001-6007"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2025/ma/d5ma00518c?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materials Advances","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/ma/d5ma00518c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Catalytic prodrug activation offers a promising approach to cancer therapy, but integrating catalytic and therapeutic functions within a single platform remains challenging. In addition, low-molecular weight metal catalysts suffer from rapid clearance and limited in vivo efficacy. Here, we present a platinum complex-conjugated polymeric micellar system, constructed from amphiphilic poly(acrylic acid)-graft-poly(propylene oxide), which self-assembles into short cylindrical micelles (ca. 50 nm in length) in aqueous solution. The micelles are functionalized with a cisplatin-derived Pt(IV) metal complex, which is released under reductive conditions and converted into catalytically active Pt(II) species capable of deprotecting an N-propargylated 5-fluorouracil prodrug. The catalytic transformation proceeds more efficiently under mildly acidic conditions (pH = 6.0), achieving up to 35% conversion after 96 hours. Cell viability assays using CT26 cancer cells showed a decrease in viability from 60% (Pt-micelle alone) to below 50% when combined with the prodrug, indicating dual catalytic and cytotoxic activity in vitro. These findings provide a proof-of-concept for a dual-functional nanocarrier system capable of localized prodrug activation and therapeutic action, offering a promising strategy for advancing metal-catalyzed cancer therapy.

Abstract Image

具有双重催化和细胞毒性活性的铂催化剂功能化圆柱形接枝共聚物胶束
催化前药活化为癌症治疗提供了一种很有前途的方法,但将催化和治疗功能整合到一个单一的平台中仍然具有挑战性。此外,低分子量金属催化剂清除速度快,体内药效有限。在这里,我们提出了一个铂配合物共轭聚合物胶束体系,由两亲性聚丙烯酸接枝聚环氧丙烷构成,它在水溶液中自组装成短的圆柱形胶束(长度约为50 nm)。胶束被顺铂衍生的铂(IV)金属配合物功能化,该配合物在还原条件下释放并转化为具有催化活性的铂(II)物质,能够去保护n-丙基化的5-氟尿嘧啶前药。在弱酸性条件下(pH = 6.0)催化转化效率更高,96小时后转化率可达35%。使用CT26癌细胞进行的细胞活力测定显示,当与前药联合使用时,细胞活力从60%(单独使用pt胶束)下降到50%以下,表明在体外具有双重催化和细胞毒性活性。这些发现为具有局部前药激活和治疗作用的双功能纳米载体系统提供了概念验证,为推进金属催化癌症治疗提供了有希望的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Materials Advances
Materials Advances MATERIALS SCIENCE, MULTIDISCIPLINARY-
CiteScore
7.60
自引率
2.00%
发文量
665
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信